DNA-based GNOS-PV01 and peptide-based NeoVax vaccines show promise for glioblastoma patients, with GNOS-PV01 effective against the challenging MGMT-unmethylated subtype.
- In the news
Moving in Cancer Discovery.
Rebuilt
DNA-based GNOS-PV01 and peptide-based NeoVax vaccines show promise for glioblastoma patients, with GNOS-PV01 effective against the challenging MGMT-unmethylated subtype.
Newest first · last 60 days
Spatial transcriptomics reveals distinct tumor cell states and multicellular niches along the core-edge axis in glioblastoma.
Neural recordings can accurately track glioma progression in vivo, with elevated gamma-band activity consistently linked to tumor growth in mouse models.
D2C7-ATC therapy is linked to prolonged survival in a subset of patients with IDHwt recurrent glioblastoma, with a median overall survival of 17.38 months in certain cases.
Fungal diversity is significantly lower in the gut of glioblastoma patients compared to healthy controls, with a p-value less than 0.001.
Reactive astrocyte-like tumor cells with mesenchymal and injury-response signatures are enriched after radiotherapy and persist in recurrent glioblastoma in a mouse model.
HERO reduces and refines whole-brain atlas-mapped cellular datasets by enabling hierarchical analysis, improving data clarity and reproducibility across neuroscience studies.
CAR-engineered microglia selectively eliminate GBM cells through phagocytosis in organoid models, showing increased phagocytic activity and tumor transcript internalization.
Levetiracetam extends survival in children with diffuse midline glioma by targeting GABAergic synapses, but not in other glioma subtypes.
Wild type bone marrow-derived microglia-like cells prevent strain-dependent thalamic calcification in Csf1r mutant mice.
Inhibiting autophagy with ATG7 silencing nanoparticles enhances radiotherapy effectiveness in high-grade mutant IDH1 gliomas, leading to tumor regression and long-term survival.
NFIs act as conserved global temporal regulators of radial glial progenitor development, with mutations causing bidirectional impairments linked to human neocortical malformations.
Aptamer-guided delivery of miR-126 significantly reduces glioblastoma stem-like cell invasion and tumor progression in mouse models.
DLL3 is essential for glioma cell viability and proliferation, with its depletion suppressing cell cycle pathways and inducing broad transcriptional reprogramming in glioma.
Spatial organization of IDH-mutant gliomas shifts from anatomy-driven in low-grade tumors to hypoxia-driven in high-grade tumors, revealing two distinct axes of tumor structure.
Mapping 202 MRI-localized biopsies from 58 glioma patients reveals three key tissue states and 14 MRI habitats linked to tumor biology and progression.
Journals this month
Topics moving, week to 23 Oct 2026